Key result
Direct oral anticoagulants lack specific antidotes for bleeding emergencies compared to vitamin K antagonists, though new antidotes are in progressive development.
Why the study?
How should bleeding associated with direct oral anticoagulants be managed?
How should bleeding associated with direct oral anticoagulants be managed?
This review highlights the clinical challenge of managing bleeding in patients on direct oral anticoagulants due to the lack of specific antidotes and anticipates future availability of reversal agents.
No takes yet. Share an insight, caveat, or question.
Requires supportive care for DOAC bleeding now; leaves open the timeline and impact of emerging antidotes.
Marano et al. (2016) conducted a review in Bleeding associated with direct oral anticoagulants. Direct oral anticoagulants vs. Vitamin K antagonists was evaluated. Direct oral anticoagulants lack specific antidotes for bleeding emergencies compared to vitamin K antagonists, though new antidotes are in progressive development.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: